Harry M Jansen Kraemer Jr has bought stock on 7 days since Aug 2021
Director at Option Care Health, Inc., and 2 other companies
SEC CIK 0001082877 · Filings on SEC.gov ↗
Harry M Jansen Kraemer Jr's record
3 months after each buy, from the first price a copier could get.
6 buys since 2021 with 3 months of prices.
Companies
Every filing
10 filings since May 2016, newest first
Option Care Health, Inc.
Director
Option Care Health, Inc.
Director
Option Care Health, Inc.
Director
Option Care Health, Inc.
Director
Option Care Health, Inc.
Director
Option Care Health, Inc.
Director
Leidos Holdings, Inc.
Director
Leidos Holdings, Inc.
Director
Option Care Health, Inc.
Director
Dentsply Sirona Inc.
Director
About Harry M Jansen Kraemer Jr
Harry M. Jansen Kraemer, Jr. is a seasoned healthcare executive and board director, currently serving as an Executive Partner at Madison Dearborn Partners since 2005 and as Clinical Professor of Management and Strategy at Northwestern University's Kellogg School of Management, where he has been recognized as Professor of the Year.( He joined the Board of Directors of Option Care Health, Inc. (OPCH) in 2019, acting as independent Board Chair, chair of the Nominating & Corporate Governance Committee, and Audit Committee member; he recently acquired 43,000 shares on November 8, 2024, bringing his ownership to approximately 326,334 shares valued at over $10 million.(
Kraemer previously served as Chairman, President, and CEO of Baxter International Inc., a $12 billion global healthcare company, from 1999 to 2005, after joining in 1982 and rising through roles including CFO and president.( His career began at Bank of America and Northwest Industries.( He holds directorships at Leidos Holdings, Inc. (LDOS), Dentsply Sirona Inc. (XRAY), Performance Health, and others, with significant equity holdings across these firms totaling an estimated net worth exceeding $63 million as of 2025.( Kraemer also serves on boards of trustees for Northwestern University and The Conference Board.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.